Four industrial CASE (iCASE) studentships are available for doctoral study at Oxford to start in October 2021. Each iCASE studentship is fully-funded for four years with a stipend of £20,000 p.a., all course fees paid, plus a research training support grant. The studentships will be based in the University as part of the Oxford-MRC Doctoral Training Partnership, and will also involve close collaboration with a commercial partner, including at least 3 months working at the company during the course of the DPhil project.
For full details, see: www.medsci.ox.ac.uk/study/graduateschool/mrcdtp/oxford-mrc-enterprise-studentships
Applications must be received by 12 noon (UK time) Friday 8 January 2021.
The projects available are:
All applications must be received by the deadline of 12 noon (UK time) Friday 8 January 2021.
|A clinically relevant musculoskeletal humanoid shoulder for biomedical applications||Details|
|Anti-S SOMAmers as functional probes and potential therapeutic agents for Covid19||Details|
|Clonal Basis of Response and Resistance to Combination Anti-Apoptotic Therapy in Patients With Acute Myeloid Leukaemia||Details|
|Development and improvement of prediction /decision making tools in treating depression in primary care||Details|
|Development of a bioelectronic system for applying chronobiology to improve the treatment of neurological disorders||Details|
|Development of Novel RF Coils for Hyperpolarized Magnetic Resonance Imaging||Details|
|Dissecting the haematological and immune components of preeclampsia and their functional significance - the role of placental extracellular vesicles||Details|
|Enhancing health and well-being across the lifespan using bio-informed lighting in the built environment||Details|
|Hybrid nanoparticles of extracellular vesicles and adeno-associated viruses (AAVs) as an innovative gene-replacement therapy for rare monogenic diseases||Details|
|Modelling ocular drug retention technologies||Details|
|Optimising CAR-T efficacy in pancreatic cancer with bioengineered scaffolds and immune agonists||Details|
|Production of SARS-CoV-2 Subunit Vaccine in Pichia pastoris||Details|
|Real-time benefit-risk assessment of vaccine exposure across a nationally representative primary care sentinel network: cutting edge technologies to prevent disease||Details|
|Using Behavioural Insights to Improve Effectiveness of Digital Weight Loss Interventions||Details|
The information you submit to this university will only be used by them to deal with your enquiry. For more information on how we use your data, please read our privacy statement